Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

This study is currently recruiting participants. (see Contacts and Locations)

Verified February 2015 by Boehringer Ingelheim

Sponsor:

Information provided by (Responsible Party):

Boehringer Ingelheim

ClinicalTrials.gov Identifier:

NCT01896297

First received: July 8, 2013

Last updated: February 20, 2015

Last verified: February 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	April 2015
Estimated Primary Completion Date:	April 2015 (Final data collection date for primary outcome measure)